BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37196052)

  • 21. Estimating the impact of single pill combination therapy for hypertension: projections of patient outcomes in Italy.
    Borghi C; Granados D
    J Cardiovasc Med (Hagerstown); 2023 Oct; 24(10):714-720. PubMed ID: 37577918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg.
    Axthelm C; Sieder C; Meister F; Kaiser E
    Curr Med Res Opin; 2012 Jan; 28(1):69-78. PubMed ID: 22117838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies.
    Dézsi CA; Glezer M; Karpov Y; Brzozowska-Villatte R; Farsang C
    Adv Ther; 2021 Jan; 38(1):479-494. PubMed ID: 33150570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined management can decrease blood pressure: an investigation of health-seeking behaviors among hypertensive patients in urban communities in China.
    Wang S; Liu K; Zhang X; Meng Q; Li X; Ye R; Zhang Z; Chen X
    BMC Cardiovasc Disord; 2021 May; 21(1):256. PubMed ID: 34034654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of valsartan and amlodipine single-pill combination in hypertensive patients (PEAK study).
    Kızılırmak P; Berktaş M; Yalçın MR; Boyacı B
    Turk Kardiyol Dern Ars; 2013 Jul; 41(5):406-17. PubMed ID: 23917006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Single-Pill, Triple Antihypertensive Therapy in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-analysis.
    Habboush S; Sofy AA; Masoud AT; Cherfaoui O; Farhat AM; Abdelsattar AT; Elmoursi A
    High Blood Press Cardiovasc Prev; 2022 May; 29(3):245-252. PubMed ID: 35325410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies.
    Farsang C; Dézsi CA; Brzozowska-Villatte R; De Champvallins M; Glezer M; Karpov Y
    Adv Ther; 2021 Apr; 38(4):1776-1790. PubMed ID: 33630277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-sectional survey evaluating blood pressure control ACHIEVEment in hypertensive patients treated with multiple anti-hypertensive agents in Belgium and Luxembourg.
    Leeman M; Dramaix M; Van Nieuwenhuyse B; Thomas JR
    PLoS One; 2018; 13(11):e0206510. PubMed ID: 30383839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
    Webster R; Salam A; de Silva HA; Selak V; Stepien S; Rajapakse S; Amarasekara S; Amarasena N; Billot L; de Silva AP; Fernando M; Guggilla R; Jan S; Jayawardena J; Maulik PK; Mendis S; Mendis S; Munasinghe J; Naik N; Prabhakaran D; Ranasinghe G; Thom S; Tisserra N; Senaratne V; Wijekoon S; Wijeyasingam S; Rodgers A; Patel A;
    JAMA; 2018 Aug; 320(6):566-579. PubMed ID: 30120478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium.
    Fagard RH; Van Den Enden M; Leeman M; Warling X
    J Hypertens; 2002 Jul; 20(7):1297-302. PubMed ID: 12131525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).
    Lu J; Lu Y; Wang X; Li X; Linderman GC; Wu C; Cheng X; Mu L; Zhang H; Liu J; Su M; Zhao H; Spatz ES; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    Lancet; 2017 Dec; 390(10112):2549-2558. PubMed ID: 29102084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature.
    Tsioufis K; Kreutz R; Sykara G; van Vugt J; Hassan T
    J Hypertens; 2020 Jun; 38(6):1016-1028. PubMed ID: 32371789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. China STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive patients: a one-year registry (China STATUS III).
    Huo Y; Gu Y; Ma G; Guo J; Xiong L; Luo Z; Xie J; Li W; Zhao J; Yan X; Liu W; Xu Y; Bao X; Zhao L; Yang M; Wang B; Iii Study Group TCS
    Curr Med Res Opin; 2019 Aug; 35(8):1441-1449. PubMed ID: 30880492
    [No Abstract]   [Full Text] [Related]  

  • 38. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.
    Jackson R
    J Hum Hypertens; 1998 Sep; 12(9):607-13. PubMed ID: 9783489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension].
    Sicras Mainar A; Galera Llorca J; Muñoz Ortí G; Navarro Artieda R
    Med Clin (Barc); 2011 Feb; 136(5):183-91. PubMed ID: 21106209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.